Bank Julius Baer & Co’s Transmedics TMDX Stock Holding History

Bank Julius Baer & Co’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$568K	Sell	5,711 -52	-0.9%	-$6.78K	﹤0.01%	428
2025 Q4	$701K	Buy	5,763 +288	+5%	+$36.1K	﹤0.01%	398
2025 Q3	$614K	Buy	5,475 +23	+0.4%	+$2.69K	﹤0.01%	402
2025 Q2	$731K	Sell	5,452 -578	-10%	-$63.5K	﹤0.01%	353
2025 Q1	$406K	Buy	6,030 +627	+12%	+$43.1K	﹤0.01%	383
2024 Q4	$372K	Buy	5,403 +693	+15%	+$64.5K	﹤0.01%	375
2024 Q3	$877K	Sell	4,710 -552	-10%	-$85.1K	﹤0.01%	296
2024 Q2	$882K	Buy	5,262 +483	+10%	+$57.9K	﹤0.01%	243
2024 Q1	$353K	Buy	+4,779	New	+$394K	﹤0.01%	344

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Julius Baer & Co's TMDX Position: Q1 2026 in Review

Bank Julius Baer & Co reduced its Transmedics (TMDX) stake by 0.9% in Q1 2026, selling an estimated $6.78K and leaving 5,711 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Bank Julius Baer & Co first reported a position in TMDX in Q1 2024 and has held it in 9 quarters since. The position peaked at $882K in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Bank Julius Baer & Co held 5,711 shares of Transmedics worth $568K as of Q1 2026.
Bank Julius Baer & Co sold 52 Transmedics shares in Q1 2026, an estimated $6.78K.
Transmedics made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #428 holding.
Bank Julius Baer & Co first reported a position in Transmedics in Q1 2024 and has held it in 9 quarters since.
Bank Julius Baer & Co's Transmedics position peaked at $882K in Q2 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.